CARR EDWARD Insider Trading -- Recent SEC Form 4 Transactions

CARR EDWARD (CIK 1273351) reported 14 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-18). Recent activity: Buy DNTH (20,000 shares), Sell DNTH (7,928 shares), Sell DNTH (6,771 shares), Sell DNTH (3,501 shares), Sell DNTH (1,100 shares). Source: SEC Form 4.

DateCompanyRoleTypeSharesValue
2026-09-18Dianthus Therapeutics, Inc. /DE/ (DNTH)CHIEF ACCOUNTING OFFICERBuy20,000$357,600
2026-09-18Dianthus Therapeutics, Inc. /DE/ (DNTH)CHIEF ACCOUNTING OFFICERSell7,928$796,209
2026-09-18Dianthus Therapeutics, Inc. /DE/ (DNTH)CHIEF ACCOUNTING OFFICERSell6,771$686,376
2026-09-18Dianthus Therapeutics, Inc. /DE/ (DNTH)CHIEF ACCOUNTING OFFICERSell3,501$358,467
2026-09-18Dianthus Therapeutics, Inc. /DE/ (DNTH)CHIEF ACCOUNTING OFFICERSell1,100$113,520
2026-09-18Dianthus Therapeutics, Inc. /DE/ (DNTH)CHIEF ACCOUNTING OFFICERSell700$73,073
2026-03-13Dianthus Therapeutics, Inc. /DE/ (DNTH)CHIEF ACCOUNTING OFFICERBuy16,182$289,334
2026-03-13Dianthus Therapeutics, Inc. /DE/ (DNTH)CHIEF ACCOUNTING OFFICERBuy17,500$386,225
2026-03-13Dianthus Therapeutics, Inc. /DE/ (DNTH)CHIEF ACCOUNTING OFFICERBuy10,000$217,700
2026-03-13Dianthus Therapeutics, Inc. /DE/ (DNTH)CHIEF ACCOUNTING OFFICERSell15,852$1.3M
2026-03-13Dianthus Therapeutics, Inc. /DE/ (DNTH)CHIEF ACCOUNTING OFFICERSell23,465$1.9M
2026-03-13Dianthus Therapeutics, Inc. /DE/ (DNTH)CHIEF ACCOUNTING OFFICERSell3,865$319,481
2026-03-13Dianthus Therapeutics, Inc. /DE/ (DNTH)CHIEF ACCOUNTING OFFICERSell200$16,676
2026-03-13Dianthus Therapeutics, Inc. /DE/ (DNTH)CHIEF ACCOUNTING OFFICERSell300$25,659

Source: SEC Form 4 filings · as of 2026-09-18